FORMULATION, OPTIMIZATION AND EVALUATION OF SUBLINGUAL FILM OF ENALAPRIL MALEATE USING 32 FULL FACTORIAL DESIGN
Objective: The purpose of this investigation was to formulate, optimize and evaluate sublingual film of Enalapril maleate for rapid management of Hypertension.
Methods: Sublingual films were prepared by solvent casting method. Present investigation were formulated by using HPMC E 15 (X1) as polymer and Polyethylene glycol (X2) as plasticizer were chosen as independent variables in 32 full factorial design while Tensile strength (TS), Disintegration time (DT) and % Cumulative drug release at 10 min. (% CDR) were taken as dependent variables. The various physical parameters were evaluated for sublingual films such as thickness, tensile strength, folding endurance, disintegration time, surface pH and % CDR.
Results: From the experimental study, it was concluded that the optimized batch F8 showed 98.6 %, the highest release of the drug. Stability study was performed by taking an optimized formulation and it was observed stable. The sublingual films showed acceptable results in all studies.
Conclusion: 32 full factorial design was successfully applied during preparation, optimization and evaluation of sublingual films of Enalapril maleate. The present investigation showed quick disintegration and fast release of the drug for rapid management of Hypertension.
Key words: Sublingual film, Hypertension, Enalapril maleate, HPMC E 15, Polyethylene glycol,
32 full factorial designs
2. Panda B.P, Dey N.S.Development of Innovation Orally Fast Disintegration Dosage Films. International Journal of Pharmaceutical Science 2012; 5:1666-1678.
3. AryaArun,Chandra Amrish. Fast Dissolving Oral Films.An Innovation Drug Delivery System and Dosage Form. International Journal Chem Tech Research 2010; 2: 576-583.
4. Mohapatra Prasanta Kumar, Ch. Pratibha, TomerVivek, Gupta Mandeep Kumar, SahooSatyajit.Design And Development Of Losartan Potassium Floating Drug Delivery Systems. International Journal of Applied Pharmaceutics 2018; 10(6):168-173.
5. Patel V, Patel F, Liu F, Brown M. Advance in oral transmucosal drug delivery. Journal of Controlled Release 2011; 153: 106-116.
6. Madhav S, Shakya A, Shakya P, Singh K.Orotransmucosal drug delivery system: A Review. Journal of Controlled Release 2009; 140: 2-11.
7. Patel KN ,Pancholi SS.Sublingual route for systemic drug delivery: A Pharmaceuitical Review. International Journal of Research in Pharmaceutical and biomedical Sciences.2012; 3(2): 913-923.
8. Arun Arya and Amrish Chandra.Fast Dissolving Oral Films.An Innovation Drug Delivery System And Dosage Form” International Journal Chem Tech Research. 2010; 2: 576-583.
9. NarangNeha, Sharma Jyoti. Sublingual Mucosa as A Route For Systemic Drug Delivery. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3(2):18-22.
10. SahooSatyajit,Makwana Ami, SahuAsitRanjan, Keshri Asha, Dash Vikash. Formulation and Evaluation of Sublingual Film of AsenapineMaleate by using 32 Full Factorial Design.Aegaeum 2020;8(4):80-94.
11. Marina Koland, V.P Sandeep.The Design and Characterization of Sublingual Films of Ondansetron Hydrochloride. International Journal Chem Sci. 2009. 7(4): 2927-2938.
12. Sahoo Satyajit, Bhatt J J, Oza N A, Sahu A R, Patel L D. Formulation Development and Optimization of Mouth Dissolving Film Containing Escitalopram Oxalate using 32 Full Factorial Design. Inventi Rapid: Pharm Tech. 2015; 4:1-7.
13. WetzelsGE, NelemansP , Schouten JS. Facts and fiction of poor compliance as a cause of Inadequate blood pressure control: A systematic review. J Hypertension 2004; 22: 1849-1855.
14. Kale Sunil, PatilAmeeta,R.H. Mandlecha. Compliance and Adverse drug Effects of
Antihypertensives in Rural India. Journal of Clinical and Diagnostic Research 2011; 5(4): 775-779.
15. Buabeng K.O., Matowe L., Plange-Rhule J. Unaffordable drug prices: A major cause of non-compliance with hypertension medication in Ghana. J Pharm Phamaceut Sc. 2004; 7(3): 350 – 352.
16. Carlson E, Chandler W, Galdo I, Kudla T. Automated integrated forced degradation and drug excipients compatibility studies. J Assoc Lab Autom 2005; 10:374-380.
17. Arya A, Chandra A, Sharma V, Pathak K. Fast Dissolving Oral Film: An Innovation Drug Delivery System And Dosage Form. International Journal of Chem Tech Research 2010; 2(1): 576-583.
18. Yellanki SK, Jagtap S, Masareddy R. Dissofilm: A novel approach for delivery of phenobarbital; design and characrization. Journal of Young Pharmacist 2013; 1(3): 181-188.
19. Kalyan S, Bansal M. Recent Trends In the Development of Oral Dissolving Film. International Journal of Pharma Tech Research 2012; 4(2):725-733.
20. Juluru N.Fast dissolving Oral Films: A Review. Internatinal Journal of Advances In Pharmacy, Biology and Chemistry 2013; 2(1):108-112.
21. Ciluzzo F, Cupone I, Minghetti P, Buratti S, Gennari C, Montanari L.Diclofenac fast-dissolving film: suppression of bitterness by a taste-sensing system. Drug Development and Industrial Pharmacy 2011; 37(3): 252-259.
22. Chauhan S, Lin S, Madan P. Preparation and evaluation of Nicotin hydrogen tartrate fast dissolving films for smoking cessation. Asian Journal of Pharmaceutical Sciences 2012; 7(3): 181-192.
23. M Koland, VP Sandeep, NR Charyulu. Fast Dissolving Sublingual Films of OndansetronHydrochloride:Effect of Additives on In Vitro Drug Release and Mucosal Permeation. Journal of Young Pharmacist 2010; 2(3): 216-222.
24. N.L Prasanthi, C. Sowmya. Design and Development of Sublingual Fast Dissolving Film for an Antiasthmatic Drug. Scholars Research Library 2012. 382-395.
25. Guideline ICH. Stability testing guidelines: stability testing of new drug substances and products. ICH Q1A (R2) (CPMP/ICH/2736/99); 1999
26. Pavia DL, Lampman GM, Kriz GS, Vyvyan JR. Introduction to Spectroscopy. 5th ed.Cengage Learning India Pvt. Ltd., India, 2015, 37-38
27. Ferreira SC, Bruns RE, Ferreira HS, Matos GD, David JM, Brandao GC. Box-behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta 2007;597:179-86.
28. Bolton S.Optimization techniques in Pharmaceutical Statistics. Practical and Clinical Applications. 3rded. New York: Marcel Dekker;1997.
This work is licensed under a Creative Commons Attribution 4.0 International License.